Selected research
Industry Research
Peptic Ulcers Treatment Industry Research Report 2026
Market perspective
The global Peptic Ulcers Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Peptic Ulcers Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Peptic Ulcers Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Peptic Ulcers Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Peptic Ulcers Treatment include Ache Laboratorios Farmaceuticos S/A, Astellas Pharma Inc., ChoDang Pharm Co., Ltd., Daewoong Pharmaceutical Co., Ltd., Kukje Pharmaceutical Industry Co., Ltd., RaQualia Pharma Inc., Sequella, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Sinil Pharmaceutical Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Peptic Ulcers Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peptic Ulcers Treatment Market by Company
Ache Laboratorios Farmaceuticos S/A
Astellas Pharma Inc.
ChoDang Pharm Co., Ltd.
Daewoong Pharmaceutical Co., Ltd.
Kukje Pharmaceutical Industry Co., Ltd.
RaQualia Pharma Inc.
Sequella, Inc.
Sihuan Pharmaceutical Holdings Group Ltd.
Sinil Pharmaceutical Co., Ltd
Yooyoung Pharmaceutical Co., Ltd
Peptic Ulcers Treatment Segment by Type
DWP-14012
DWJ-206
BGC-001
ASP-6537
Others
Peptic Ulcers Treatment Segment by Application
Hospital
Clinic
Others
Peptic Ulcers Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptic Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptic Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptic Ulcers Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peptic Ulcers Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peptic Ulcers Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peptic Ulcers Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DWP-14012
- DWJ-206
- BGC-001
- ASP-6537
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Ache Laboratorios Farmaceuticos S/A
- Astellas Pharma Inc.
- ChoDang Pharm Co., Ltd.
- Daewoong Pharmaceutical Co., Ltd.
- Kukje Pharmaceutical Industry Co., Ltd.
- RaQualia Pharma Inc.
- Sequella, Inc.
- Sihuan Pharmaceutical Holdings Group Ltd.
- Sinil Pharmaceutical Co., Ltd
- Yooyoung Pharmaceutical Co., Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Peptic Ulcers Treatment Market Size (2021-2032)
- 2.2.2 Global Peptic Ulcers Treatment Sales (2021-2032)
- 2.2.3 Global Peptic Ulcers Treatment Market Average Price (2021-2032)
- 2.3 Peptic Ulcers Treatment by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DWP-14012
- 2.3.3 DWJ-206
- 2.3.4 BGC-001
- 2.3.5 ASP-6537
- 2.3.6 Others
- 2.4 Peptic Ulcers Treatment by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Peptic Ulcers Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Peptic Ulcers Treatment Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Peptic Ulcers Treatment Revenue of Manufacturers (2021-2026)
- 3.4 Global Peptic Ulcers Treatment Average Price by Manufacturers (2021-2026)
- 3.5 Global Peptic Ulcers Treatment Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Peptic Ulcers Treatment, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Peptic Ulcers Treatment, Product Type & Application
- 3.8 Global Manufacturers of Peptic Ulcers Treatment, Established Date
- 3.9 Global Peptic Ulcers Treatment Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ache Laboratorios Farmaceuticos S/A
- 4.1.1 Ache Laboratorios Farmaceuticos S/A Company Information
- 4.1.2 Ache Laboratorios Farmaceuticos S/A Business Overview
- 4.1.3 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ache Laboratorios Farmaceuticos S/A Peptic Ulcers Treatment Product Portfolio
- 4.1.5 Ache Laboratorios Farmaceuticos S/A Recent Developments
- 4.2 Astellas Pharma Inc.
- 4.2.1 Astellas Pharma Inc. Company Information
- 4.2.2 Astellas Pharma Inc. Business Overview
- 4.2.3 Astellas Pharma Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Astellas Pharma Inc. Peptic Ulcers Treatment Product Portfolio
- 4.2.5 Astellas Pharma Inc. Recent Developments
- 4.3 ChoDang Pharm Co., Ltd.
- 4.3.1 ChoDang Pharm Co., Ltd. Company Information
- 4.3.2 ChoDang Pharm Co., Ltd. Business Overview
- 4.3.3 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 ChoDang Pharm Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 4.3.5 ChoDang Pharm Co., Ltd. Recent Developments
- 4.4 Daewoong Pharmaceutical Co., Ltd.
- 4.4.1 Daewoong Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Daewoong Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Daewoong Pharmaceutical Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 4.4.5 Daewoong Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Kukje Pharmaceutical Industry Co., Ltd.
- 4.5.1 Kukje Pharmaceutical Industry Co., Ltd. Company Information
- 4.5.2 Kukje Pharmaceutical Industry Co., Ltd. Business Overview
- 4.5.3 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kukje Pharmaceutical Industry Co., Ltd. Peptic Ulcers Treatment Product Portfolio
- 4.5.5 Kukje Pharmaceutical Industry Co., Ltd. Recent Developments
- 4.6 RaQualia Pharma Inc.
- 4.6.1 RaQualia Pharma Inc. Company Information
- 4.6.2 RaQualia Pharma Inc. Business Overview
- 4.6.3 RaQualia Pharma Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 RaQualia Pharma Inc. Peptic Ulcers Treatment Product Portfolio
- 4.6.5 RaQualia Pharma Inc. Recent Developments
- 4.7 Sequella, Inc.
- 4.7.1 Sequella, Inc. Company Information
- 4.7.2 Sequella, Inc. Business Overview
- 4.7.3 Sequella, Inc. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sequella, Inc. Peptic Ulcers Treatment Product Portfolio
- 4.7.5 Sequella, Inc. Recent Developments
- 4.8 Sihuan Pharmaceutical Holdings Group Ltd.
- 4.8.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
- 4.8.2 Sihuan Pharmaceutical Holdings Group Ltd. Business Overview
- 4.8.3 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sihuan Pharmaceutical Holdings Group Ltd. Peptic Ulcers Treatment Product Portfolio
- 4.8.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
- 4.9 Sinil Pharmaceutical Co., Ltd
- 4.9.1 Sinil Pharmaceutical Co., Ltd Company Information
- 4.9.2 Sinil Pharmaceutical Co., Ltd Business Overview
- 4.9.3 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sinil Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
- 4.9.5 Sinil Pharmaceutical Co., Ltd Recent Developments
- 4.10 Yooyoung Pharmaceutical Co., Ltd
- 4.10.1 Yooyoung Pharmaceutical Co., Ltd Company Information
- 4.10.2 Yooyoung Pharmaceutical Co., Ltd Business Overview
- 4.10.3 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Yooyoung Pharmaceutical Co., Ltd Peptic Ulcers Treatment Product Portfolio
- 4.10.5 Yooyoung Pharmaceutical Co., Ltd Recent Developments
5 Global Peptic Ulcers Treatment Market Scenario by Region
- 5.1 Global Peptic Ulcers Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Peptic Ulcers Treatment Sales by Region: 2021-2032
- 5.2.1 Global Peptic Ulcers Treatment Sales by Region: 2021-2026
- 5.2.2 Global Peptic Ulcers Treatment Sales by Region: 2027-2032
- 5.3 Global Peptic Ulcers Treatment Revenue by Region: 2021-2032
- 5.3.1 Global Peptic Ulcers Treatment Revenue by Region: 2021-2026
- 5.3.2 Global Peptic Ulcers Treatment Revenue by Region: 2027-2032
- 5.4 North America Peptic Ulcers Treatment Market Facts & Figures by Country
- 5.4.1 North America Peptic Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Peptic Ulcers Treatment Sales by Country (2021-2032)
- 5.4.3 North America Peptic Ulcers Treatment Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Peptic Ulcers Treatment Market Facts & Figures by Country
- 5.5.1 Europe Peptic Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Peptic Ulcers Treatment Sales by Country (2021-2032)
- 5.5.3 Europe Peptic Ulcers Treatment Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Peptic Ulcers Treatment Market Facts & Figures by Country
- 5.6.1 Asia Pacific Peptic Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Peptic Ulcers Treatment Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Peptic Ulcers Treatment Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Peptic Ulcers Treatment Market Facts & Figures by Country
- 5.7.1 South America Peptic Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Peptic Ulcers Treatment Sales by Country (2021-2032)
- 5.7.3 South America Peptic Ulcers Treatment Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Peptic Ulcers Treatment Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Peptic Ulcers Treatment Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Peptic Ulcers Treatment Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Peptic Ulcers Treatment Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Peptic Ulcers Treatment Sales by Type (2021-2032)
- 6.1.1 Global Peptic Ulcers Treatment Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Peptic Ulcers Treatment Sales Market Share by Type (2021-2032)
- 6.2 Global Peptic Ulcers Treatment Revenue by Type (2021-2032)
- 6.2.1 Global Peptic Ulcers Treatment Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Peptic Ulcers Treatment Revenue Market Share by Type (2021-2032)
- 6.3 Global Peptic Ulcers Treatment Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Peptic Ulcers Treatment Sales by Application (2021-2032)
- 7.1.1 Global Peptic Ulcers Treatment Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Peptic Ulcers Treatment Sales Market Share by Application (2021-2032)
- 7.2 Global Peptic Ulcers Treatment Revenue by Application (2021-2032)
- 7.2.1 Global Peptic Ulcers Treatment Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Peptic Ulcers Treatment Revenue Market Share by Application (2021-2032)
- 7.3 Global Peptic Ulcers Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Peptic Ulcers Treatment Value Chain Analysis
- 8.1.1 Peptic Ulcers Treatment Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Peptic Ulcers Treatment Production Mode & Process
- 8.2 Peptic Ulcers Treatment Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Peptic Ulcers Treatment Distributors
- 8.2.3 Peptic Ulcers Treatment Customers
9 Global Peptic Ulcers Treatment Analyzing Market Dynamics
- 9.1 Peptic Ulcers Treatment Industry Trends
- 9.2 Peptic Ulcers Treatment Industry Drivers
- 9.3 Peptic Ulcers Treatment Industry Opportunities and Challenges
- 9.4 Peptic Ulcers Treatment Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst